As summarized in Figure 7, our present findings demonstrate for the first time that aspirin and Compound C inhibited expression of lipogenesis-related key enzymes via c-myc inhibition to attenuate fatty acid metabolism and inhibit tumor growth in HER-2-positive breast cancer. This evidence concerns the gene ERBB2 and breast carcinoma.